Apoptosis in ocular disease: A molecular overview

Ophthalmic Genetics

Volumn 17, Issue 4, 1996, Pages 145-165

  Nickells, Robert W ^a   Zack, Donald J ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell death; Genes; Ocular disease

Indexed keywords

DNA FRAGMENT; GROWTH FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; PROTEINASE;

APOPTOSIS; CATARACT; CELL CYCLE; CELL DAMAGE; CELL ULTRASTRUCTURE; DIABETIC RETINOPATHY; DNA DEGRADATION; EYE DISEASE; GENETIC REGULATION; GLAUCOMA; HUMAN; NEMATODE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RETINA ISCHEMIA; RETINA MACULA DEGENERATION; RETINITIS PIGMENTOSA; RETINOBLASTOMA; REVIEW;

EID: 0030446479     PISSN: 01676784     EISSN: None     Source Type: Journal    
DOI: 10.3109/13816819609057889     Document Type: Review

References (121)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
2. Schwartz LM, Smith SW, Jones MEE, Osborne BA. Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci USA 1993; 90: 980-984.
3. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990; 136: 593-608.
4. Batistatou A, Greene LA. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol 1991; 115: 461-471.
5. Batistatou A, Greene LA. Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 1993; 122: 523-532.
6. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
7. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron 1992; 9: 383-391.
8. Martin DP, Ito A, Horigome K, Lampe PA, Johnson Jr EM. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J Neurobiol 1992; 23: 1205-1220.
9. Johnson JE, Barde Y-A, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 1986; 6: 3031-3038.
10. Rodriguez-Tébar A, Jeffrey PL, Thoenen H, Barde YA. The survival of chick retinal ganglion cells in response to brain-derived neurotrophic factor depends on their embryonic age. Dev Biol 1989; 136: 296-303.
11. Cohen-Cory S, Fraser SE. BDNF in the development of the visual system of Xenopus. Neuron 1994; 12: 747-761.
12. Cleveland JH, Ihle JN. Contenders in FasL/TNF death signaling. Cell 1995; 81: 479-482.
13. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and macromolecular synthesis. J Pathol 1984; 142: 67-77.
14. Sulston JE, Horvitz HR. Post-embryonic cell lineages of the nematode Caenorhabditis elegans. Dev Biol 1977; 56: 110-156.
15. Sulston JE, Schierenberg E, White JG, Thomson N. The embryonic lineage of the nematode Caenorhabditis elegans. Dev Biol 1983; 100: 64-119.
16. Ellis RE, Yuan J, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7: 663-698.
17. Yuan J, Horvitz HR. Genetic mosaic analyses of ced-3 and ced-4, two genes that control programmed cell death in the nematode C. elegans. Dev Biol 1990; 138: 33-41.
18. Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 356: 494-499.
19. Tsujimoto Y, Gorham J, Crossman J, Jaffe E, Croce CM. The t(14; 18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229: 1390-1393.
20. Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14; 18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
21. Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14; 18) translocation. Cell 1986; 47: 19-28.
22. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214-5218.
23. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
24. Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 1993; 90: 2189-2193.
25. Garcia I, Martinou I, Tsujimoto Y, Martinou J-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene Science 1992; 258: 302-304.
26. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993; 73: 295-307.
27. Zhong L, Kane DJ, Bredesen DE. BCL-2 blocks glutamate toxicity in neural cell lines. Mol Brain Res 1993; 19: 353-355.
28. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 1993; 60: 1183-1186.
29. Martinou J-C, Dubois-Dauphin M, Staple JK, et al. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death an experimental ischemia. Neuron 1994; 13: 1017-1030.
30. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76: 665-676.
31. Yin X-M, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 1994; 369: 321-323.
32. Vaux DL, Weissman IL, Kim SK. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 1992; 258: 1955-1957.
33. Boise LH, González-García M, Postema CE, et al. bcl-x, a bcl-2-relaled gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
34. Oltvai Z, Milliman C, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
35. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-779.
36. L and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
37. Kiefer MC, Brauner MJ, Powers VC, et al. Cdn-1, -2 and -3, a family of bcl-2 related genes that modulate apoptosis. Genetic and biochemical approaches for studying cell death. Abstracts for the Fall Symposium of the American Society for Biochemistry and Molecular Biology. 1994; 10: 6a.
38. González-García M, García I, Ding L, et al. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 1995; 92: 4304-4308.
39. Greenlund LJS, Deckwerth TL, Johnson JEM. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14: 303-315.
40. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondria. Nature 1993; 361: 365-369.
41. Marx J. How p53 suppresses cell growth. Science 1993; 262: 1644-1645.
42. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
43. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
44. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-4499.
45. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552-554.
46. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 protooncogenes. Nature 1992; 359: 554-556.
47. Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 1993; 13: 2432-2440.
48. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
49. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994; 91: 5878-5882.
50. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 1994; 54: 3131-3135.
51. Miyashita T, Reed JC. Tumor supressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-299.
52. Finke J, Firtzen R, Terres P, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992; 80: 459-469.
53. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 1991; 349: 254-256.
54. Yuan J, Horvitz HR. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 1992; 116: 309-320.
55. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993; 75: 641-652.
56. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by interleukin-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993; 75: 653-660.
57. Gagliardini V, Fernandez P-A, Lee RKK, et al. Prevention of vertebrate neuronal death by the crmA gene. Science 1994; 263: 826-828.
58. Fernandez-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Ceanorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
59. Tewari M, Quan LT, O'Rourke K, et al. Yama/Cpp32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate ploy (ADP-ribose) polymerase.Cell 1995; 81: 801-809.
60. Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279-284.
61. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H. Genetic control of programmed cell death in Drosophila. Science 1994; 264: 677-683.
62. Golstein P, Marguuet D, Depraetere V. Homology between Reaper and the cell death domains of Fas and TNFR 1. Cell 1995; 81: 185-186.
63. Pronk GJ, Ramer K, Amiri P, Williams LT. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science 1996; 271: 808-810.
64. Raff MC. Cell death genes: Drosophila enters the field. Science 1994; 264: 668-669.
65. Büchi ER, Bernauer W, Daicker B. Cell death and disposal in retinoblastoma: an electron microscopic study. Graefe's Arch Clin Exp Ophthalmol 1994; 232: 635-645.
66. Nork TM, Poulsen G, Millecchia LL, Jantz RG, Nickells RW. p53 regulates apoptosis in human retinoblastoma. Arch Ophthalmol 1997; in press.
67. Howes KA, Ransom N, Papermaster DS, Lasudry JGH, Albert DM, Windle JJ. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 1994; 8: 1300-1310.
68. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234.
69. Shields CL, Shields JA, Baez KA, Cater J, De Potter PV. Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors. Br J Ophthalmol 1993; 77: 544-548.
70. Knudson AJ. Mutation and childhood cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-823.
71. Hamel PA, Phillips RA, Muncaster M, Gallie BL. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J 1993; 7: 846-854.
72. Albert DM, Griep AE, Lambert PF, Howes KA, Windle JJ, Lasudry JHG. Transgenic models of retinoblastoma: what they tell us about its cause and treatment. Trans Am Ophthalmol Soc 1994; 92: 385-401.
73. Al-Ubaidi MR, Font RL, Quiambao AB, et al. Bilateral retinal and brain tumors in transgenic mice expressing Simian Virus 40 Large T-antigen under control of the human inter-photoreceptor retinoid-binding protein promoter. J Cell Biol 1992; 119: 1681-1687.
74. Chang G-Q, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993; ii: 595-605.
75. Portera-Cailliau C, Sung C-H, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 1994; 91: 974-978.
76. Lolley RN, Rong H, Craft CM. Linkage of photoreceptor degeneration by apoptosis with inherited defect in phototransduction. Invest Ophthalmol Vis Sci 1994; 35: 358-362.
77. Sung C-H, Schneider BG, Agarwal N, Papermaster DS, Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA 1991; 88: 8840-8844.
78. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, La Vail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347: 83-86.
79. Campochiaro PA, Chang M, Ohsato M, et al. Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor. J Neurosci 1996; 16: 1679-1688.
80. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci 1980; 19: 137-152.
81. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36: 774-786.
82. Büchi ER. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer. Exp Eye Res 1992; 55: 605-613.
83. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995; 61: 33-44.
84. Levin LA, Louhab A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch Ophthalmol 1996; 114: 488-491.
85. Berkelaar M, Clarke DB, Wang Y-C, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994; 14: 4368-4374.
86. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994; 25: 431-438.
87. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J Glaucoma 1996; 5: 345-356.
88. Radius RL, Anderson DR. Rapid axonal transport in primate optic nerve. Arch Ophthalmol 1981; 99: 650-654.
89. Mansour-Robaey S, Clarke DB, Wang Y-C, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994; 91: 1632-1636.
90. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996; 114: 299-305.
91. Dreyer EB, Pan ZH, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport 1994; 5: 629-631.
92. Nork TM, Millecchia LL, Strickland BD, Linberg JV, Chao G-M. Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol 1995; 113: 1066-1073.
93. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 1995; 36: 990-996.
94. Chang C-J, Lai WW, Edward DP, T'so MOM. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol 1995; 113: 880-886.
95. Büchi ER. Cell death in rat retina after pressure-induced ischaemia-reperfusion insult: electron microscopic study. II. Outer nuclear layer. Jpn J Ophthalmol 1992; 36: 62-68.
96. Linnik MD, Zobrist RH, Hatfield MD. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24: 2002-2008.
97. MacManus JP, Hill IE, Huang ZG, Rasquinha I, Xue D, Buchan AM. DNA damage consistent with apoptosis in transient focal ischaemic neocortex. Neuroreport 1994; 5: 493-496.
98. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate of nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92: 7162-7166.
99. Stamler J. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994; 78: 931-936.
100. Dreyer EB, Zhang D, Lipton SA. Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death. Neuroreport 1995; 6: 942-944.
101. Fromm L, Shawlot W, Gunning K, Butel JS, Overbeek PA. The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol Cell Biol 1994; 14: 6743-6754.
102. Pan H, Griep AE. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 1994; 8: 1285-1299.
103. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced in Rb-deficiency in the developing mouse lens. Nature 1994; 371: 72-74.
104. Li W-C, Kuszak JR, Dunn K, et al. Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals. J. Cell Biol 1995; 130: 169-181.
105. Spector A. The lens and oxidative stress. In: Sies H, editor. Oxidative Stress, Oxidants and Antioxidants. London: Academic Press, 1991; 529-558.
106. Burns RP, Feeney-Burns L. Clinicomorphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc 1980; LXXCVIII: 206-225.
107. Sahel JA, Brini A, Albert DM. Pathology of the retina and vitreous. In: Albert DM, Jakobiec FA, editors. Principles and Practice of Ophthalmology, Vol. 4. Philadelphia: Saunders, 1994; 2239-2280.
108. Okun E. Gross and microscopic pathology in autopsy eyes. II. Perichoroidal atrophy. Am J Ophthalmol 1960; 50: 574-583.
109. Bonfanti L, Strettoi E, Chierzi S, et al. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice overexpressing bcl-2. J Neurosci 1996; 16: 4186-4194.
110. Zack DJ. Ocular gene therapy. From fantasy to foreseeable reality. Arch Ophthalmol 1993; 111: 1477-1479.
111. Pepose JS, Leib DA. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Invest Ophthalmol Vis Sci 1994; 35: 2662-2666.
112. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene tranfer into adult murine retina. Invest Ophthalmol Vis Sci 1994; 35: 2535-2542.
113. Li T, Adamian M, Roof DJ, et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest Ophthalmol Vis Sci 1994; 35: 2543-2549.
114. Adler R. Mechanisms of photoreceptor death in retinal degenerations: from the cell biology in the 1990s to the ophthalmology of the 21st century? Arch Ophthalmol 1996; 114: 79-83.
115. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-622.
116. Chen H-S, Pellegrini JW, Aggarwal SK, et al. Open-channel block of N-methyl-D-asparate (NMDA) responses by memantine: therapetic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12: 4427-4436.
117. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sabel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996; 37: 1618-1624.
118. Fox DA, Campbell ML, Blocker YS. Functional alterations and apoptotic cell death in the retina following developmental or adult lead exposure. Neurotoxicology 1996; in press.
119. White E. Death-defying acts: a meeting review on apoptosis. Genes Dev 1993; 7: 2277-2284.
120. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449.
121. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase. Nature 1990; 347: 677-680.